Oncology PracticeAdvance care planning codes not being usedMarch 14, 2019Practice ManagementBusiness of Medicine
Oncology Practice‘Difficult’ discussions reduced anxiety, depression in life-limiting cancer patientsMarch 14, 2019Patient & Survivor CarePractice ManagementBusiness of Medicine
Oncology PracticeClinical trials unavailable for more than half of all cancer patientsMarch 14, 2019Practice ManagementBusiness of Medicine
Oncology PracticePrior authorization an increasing burdenMarch 13, 2019Practice ManagementBusiness of Medicine
Hematology NewsScott Gottlieb to step down as FDA commissionerMarch 5, 2019Practice ManagementBusiness of Medicine
Oncology PracticeGroups of physicians produce more accurate diagnoses than individualsMarch 5, 2019Business of MedicinePractice Management
Oncology PracticeDrug pricing does not inspire Americans’ trustMarch 5, 2019Practice ManagementBusiness of Medicine
Oncology PracticeFDA Expanded Access benefits heavily pretreated patients, especially childrenMarch 4, 2019Practice ManagementCNS/Brain CancerBreast CancerLung CancerBusiness of Medicine
Oncology PracticeMalpractice suits are less frequent – but more costlyMarch 2, 2019Practice ManagementBusiness of Medicine
Hematology NewsBig pharma says it can’t drop drug list prices aloneFebruary 27, 2019Business of MedicinePractice Management
Hematology NewsWhat does 'Medicare for all' mean?February 27, 2019Business of MedicinePractice Management
Oncology PracticeModel shows nivolumab plus ipilimumab cost effective in mRCCFebruary 25, 2019Practice ManagementGenitourinary CancerRenal Cell CarcinomaImmuno-oncologyBusiness of Medicine
Oncology PracticeTalk about déjà vu: Senators set to re-enact drug price hearing of 60 years agoFebruary 25, 2019Practice ManagementBusiness of Medicine
